Skip UCSF navigation|About accessibility UCSF University of California, San Francisco
About UCSF
Search UCSF
UCSF Medical Center
End of UCSF navigation

End of section-level navigation

Skip breadcrumbs navigationUCSF which contains School of Pharmacy which contains News Archive which contains Use of Amyloid Inhibitors Cautioned
School of Pharmacy

UCSF School of Pharmacy

News Archive

Use of Amyloid Inhibitors Cautioned

Thursday, January 31, 2008

Shoichet Brian Shoichet, PhD, School of Pharmacy faculty member and Brian Feng, PhD, former staff research associate with the School, and colleagues have discovered that many amyloid inhibitors, which scientists had hoped would keep "sticky" amyloid protein fibers such as those associated with Alzheimer's disease from aggregating in brain tissue, actually clump together themselves. This would make these amyloid inhibitors useless as targeted therapies against amyloid in the brain. In addition, in their clumped form, they inhibit most other proteins with which they come in contact. Their work appears in the January 27, 2008 issue of Nature Chemical Biology under the title "Small-molecule aggregates inhibit amyloid polymerization."

"A cautionary conclusion to emerge from these studies," write the authors, "is that chemical aggregators may be common among inhibitors of amyloid fibrillization."

Full Story

Small molecule aggregates inhibit amyloid polymerization

Go To: UCSF School of Pharmacy News

Other News